Theo de Reijke

Amsterdam UMC Location University of Amsterdam

Papers

1

Total Citations

164

H-Index

1

About

Theo de Reijke is a leading figure in uro-oncology, with a primary focus on prostate cancer management and clinical guideline development. His most cited work, the 2013 ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of prostate cancer (164 citations), has shaped international standards of care, providing evidence-based frameworks that guide clinicians from initial diagnosis through long-term patient monitoring. Beyond this landmark contribution, de Reijke has advanced understanding of multimodal treatment strategies, including the integration of surgery, radiotherapy, and systemic therapies for localized and advanced disease. His research emphasizes the importance of personalized treatment pathways and quality-of-life outcomes, influencing both clinical practice and trial design. With a career spanning decades, de Reijke’s impact is reflected in the widespread adoption of his guidelines and his role in mentoring the next generation of urologic oncologists. His work remains essential reading for researchers and clinicians seeking to navigate the complexities of prostate cancer care, underscoring his legacy as a pivotal architect of modern uro-oncology standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
164
Total Citations
164
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
164 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Amsterdam UMC Location University of Amsterdam

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago